 | • レポートコード：QAF27645 • 出版社/出版日：QYResearch / 2021年4月14日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、145ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界の糖尿病治療薬市場について種類別（スルホニル尿素剤、ビグアニド剤、メグリチニド剤、チアゾリジンジオン剤、アルファ-グルコシダーゼ阻害剤、DPP-4阻害剤、SGLT-2阻害剤）、用途別（診断/クリニック、ICU、在宅医療）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・糖尿病治療薬市場の概要 ・世界の主要地域別糖尿病治療薬市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界の糖尿病治療薬市場規模2016-2021：種類別（スルホニル尿素剤、ビグアニド剤、メグリチニド剤、チアゾリジンジオン剤、アルファ-グルコシダーゼ阻害剤、DPP-4阻害剤、SGLT-2阻害剤） ・世界の糖尿病治療薬市場予測2012-2027：種類別（スルホニル尿素剤、ビグアニド剤、メグリチニド剤、チアゾリジンジオン剤、アルファ-グルコシダーゼ阻害剤、DPP-4阻害剤、SGLT-2阻害剤） ・世界の糖尿病治療薬市場規模2016-2021：用途別（診断/クリニック、ICU、在宅医療） ・世界の糖尿病治療薬市場予測2012-2027：用途別（診断/クリニック、ICU、在宅医療） ・糖尿病治療薬のアメリカ市場規模と予測2016-2021 ・糖尿病治療薬のヨーロッパ市場規模と予測2016-2021 ・糖尿病治療薬の中国市場規模と予測2016-2021 ・糖尿病治療薬の日本市場規模と予測2016-2021 ・糖尿病治療薬の東南アジア市場規模と予測2016-2021 ・糖尿病治療薬のインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Sanofi、Novo Nordisk、MSD、Astrazeneca、Takeda、Novartis、North China Pharmaceutical Group Corporation、Huadong Medicine、Dongbao Pharmaceutical、Hisun Pharmacy、KELUN、Ginwa、Tianan Pharmaceutical、Jumpcan Pharmacy、Guangzhou Baiyun Mountain、SHIJIAZHUANG YILING PHARMACEUTICAL、Wanbang Biopharmaceuticals、Gan & Lee、Taloph） ・糖尿病治療薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・糖尿病治療薬の市場動向・機会・課題 ・調査の結論 |
Diabetes is a condition that keeps your body from making enough insulin. Insulin is a hormone that’s made by an organ called the pancreas. When the body doesn’t make enough insulin, sugar builds up in the blood instead of moving to cells and being used for energy. This causes blood sugar to be high. If blood sugar stays high for a long time, it can cause serious health problems – including blindness, kidney damage, heart disease and stroke. That’s why it’s important to take medicine that helps lower blood sugar levels. Diabetes can be managed so you can live a normal, healthy life.
All diabetes drugs work to lower the levels of sugar in the blood. There are two basic types of diabetes drugs: pills by mouth and shots injected into the skin. More than one drug is often needed to manage diabetes. Some people try different pills, take more than one pill, or take a pill along with shots.
As World overall economic downward trend in the past few years, and international economic situation is complicated, in the next few years there will be many uncertainties, coupled with diabetes drug industry in short supply on the market in the past few years, more companies will enter into the diabetes drug industry, the current demand for diabetes drug product is relatively high; comparing to the ordinary diabetes drug products selling on the market. Diabetes drug’s price remains in the same level as compared with the past years. The signal of market price change indicates the trend in the diabetes drug industry, the market still have large potential.
Market Analysis and Insights: Global Diabetes Drugs Market
The global Diabetes Drugs market was valued at US$ 70970 in 2020 and will reach US$ 97290 million by the end of 2027, growing at a CAGR of 5.4% during 2022-2027.
Global Diabetes Drugs Scope and Market Size
The global Diabetes Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Diabetes Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Sulphonylureas
Biguanides
Meglitinides
Thiazolidinediones
Alpha-glucosidase Inhibitors
DPP-4 Inhibitors
SGLT-2 Inhibitors
Segment by Application
Diagnostic/Clinics
ICUs
Home Healthcare
The Diabetes Drugs market is analysed and market size information is provided by regions (countries). Segment by Application, the Diabetes Drugs market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Sanofi
Novo Nordisk
MSD
Astrazeneca
Takeda
Novartis
North China Pharmaceutical Group Corporation
Huadong Medicine
Dongbao Pharmaceutical
Hisun Pharmacy
KELUN
Ginwa
Tianan Pharmaceutical
Jumpcan Pharmacy
Guangzhou Baiyun Mountain
SHIJIAZHUANG YILING PHARMACEUTICAL
Wanbang Biopharmaceuticals
Gan & Lee
Taloph
1 Diabetes Drugs Market Overview
1.1 Diabetes Drugs Product Scope
1.2 Diabetes Drugs Segment by Type
1.2.1 Global Diabetes Drugs Sales by Type (2016 & 2021 & 2027)
1.2.2 Sulphonylureas
1.2.3 Biguanides
1.2.4 Meglitinides
1.2.5 Thiazolidinediones
1.2.6 Alpha-glucosidase Inhibitors
1.2.7 DPP-4 Inhibitors
1.2.8 SGLT-2 Inhibitors
1.3 Diabetes Drugs Segment by Application
1.3.1 Global Diabetes Drugs Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Diagnostic/Clinics
1.3.3 ICUs
1.3.4 Home Healthcare
1.4 Diabetes Drugs Market Estimates and Forecasts (2016-2027)
1.4.1 Global Diabetes Drugs Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Diabetes Drugs Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Diabetes Drugs Price Trends (2016-2027)
2 Diabetes Drugs Estimates and Forecasts by Region
2.1 Global Diabetes Drugs Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Diabetes Drugs Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Diabetes Drugs Sales Market Share by Region (2016-2021)
2.2.2 Global Diabetes Drugs Revenue Market Share by Region (2016-2021)
2.3 Global Diabetes Drugs Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Diabetes Drugs Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Diabetes Drugs Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Diabetes Drugs Estimates and Projections (2016-2027)
2.4.2 Europe Diabetes Drugs Estimates and Projections (2016-2027)
2.4.3 China Diabetes Drugs Estimates and Projections (2016-2027)
2.4.4 Japan Diabetes Drugs Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Diabetes Drugs Estimates and Projections (2016-2027)
2.4.6 India Diabetes Drugs Estimates and Projections (2016-2027)
3 Global Diabetes Drugs Competition Landscape by Players
3.1 Global Top Diabetes Drugs Players by Sales (2016-2021)
3.2 Global Top Diabetes Drugs Players by Revenue (2016-2021)
3.3 Global Diabetes Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Diabetes Drugs as of 2020)
3.4 Global Diabetes Drugs Average Price by Company (2016-2021)
3.5 Manufacturers Diabetes Drugs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Diabetes Drugs Market Size by Type
4.1 Global Diabetes Drugs Historic Market Review by Type (2016-2021)
4.1.1 Global Diabetes Drugs Sales Market Share by Type (2016-2021)
4.1.2 Global Diabetes Drugs Revenue Market Share by Type (2016-2021)
4.1.3 Global Diabetes Drugs Price by Type (2016-2021)
4.2 Global Diabetes Drugs Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Diabetes Drugs Sales Forecast by Type (2022-2027)
4.2.2 Global Diabetes Drugs Revenue Forecast by Type (2022-2027)
4.2.3 Global Diabetes Drugs Price Forecast by Type (2022-2027)
5 Global Diabetes Drugs Market Size by Application
5.1 Global Diabetes Drugs Historic Market Review by Application (2016-2021)
5.1.1 Global Diabetes Drugs Sales Market Share by Application (2016-2021)
5.1.2 Global Diabetes Drugs Revenue Market Share by Application (2016-2021)
5.1.3 Global Diabetes Drugs Price by Application (2016-2021)
5.2 Global Diabetes Drugs Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Diabetes Drugs Sales Forecast by Application (2022-2027)
5.2.2 Global Diabetes Drugs Revenue Forecast by Application (2022-2027)
5.2.3 Global Diabetes Drugs Price Forecast by Application (2022-2027)
6 North America Diabetes Drugs Market Facts & Figures
6.1 North America Diabetes Drugs Sales by Company
6.1.1 North America Diabetes Drugs Sales by Company (2016-2021)
6.1.2 North America Diabetes Drugs Revenue by Company (2016-2021)
6.2 North America Diabetes Drugs Sales Breakdown by Type
6.2.1 North America Diabetes Drugs Sales Breakdown by Type (2016-2021)
6.2.2 North America Diabetes Drugs Sales Breakdown by Type (2022-2027)
6.3 North America Diabetes Drugs Sales Breakdown by Application
6.3.1 North America Diabetes Drugs Sales Breakdown by Application (2016-2021)
6.3.2 North America Diabetes Drugs Sales Breakdown by Application (2022-2027)
7 Europe Diabetes Drugs Market Facts & Figures
7.1 Europe Diabetes Drugs Sales by Company
7.1.1 Europe Diabetes Drugs Sales by Company (2016-2021)
7.1.2 Europe Diabetes Drugs Revenue by Company (2016-2021)
7.2 Europe Diabetes Drugs Sales Breakdown by Type
7.2.1 Europe Diabetes Drugs Sales Breakdown by Type (2016-2021)
7.2.2 Europe Diabetes Drugs Sales Breakdown by Type (2022-2027)
7.3 Europe Diabetes Drugs Sales Breakdown by Application
7.3.1 Europe 145 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 145 Sales Breakdown by Application (2022-2027)
8 China Diabetes Drugs Market Facts & Figures
8.1 China Diabetes Drugs Sales by Company
8.1.1 China Diabetes Drugs Sales by Company (2016-2021)
8.1.2 China Diabetes Drugs Revenue by Company (2016-2021)
8.2 China Diabetes Drugs Sales Breakdown by Type
8.2.1 China Diabetes Drugs Sales Breakdown by Type (2016-2021)
8.2.2 China Diabetes Drugs Sales Breakdown by Type (2022-2027)
8.3 China Diabetes Drugs Sales Breakdown by Application
8.3.1 China 314 Sales Breakdown by Application (2016-2021)
8.3.2 China 314 Sales Breakdown by Application (2022-2027)
9 Japan Diabetes Drugs Market Facts & Figures
9.1 Japan Diabetes Drugs Sales by Company
9.1.1 Japan Diabetes Drugs Sales by Company (2016-2021)
9.1.2 Japan Diabetes Drugs Revenue by Company (2016-2021)
9.2 Japan Diabetes Drugs Sales Breakdown by Type
9.2.1 Japan Diabetes Drugs Sales Breakdown by Type (2016-2021)
9.2.2 Japan Diabetes Drugs Sales Breakdown by Type (2022-2027)
9.3 Japan Diabetes Drugs Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Diabetes Drugs Market Facts & Figures
10.1 Southeast Asia Diabetes Drugs Sales by Company
10.1.1 Southeast Asia Diabetes Drugs Sales by Company (2016-2021)
10.1.2 Southeast Asia Diabetes Drugs Revenue by Company (2016-2021)
10.2 Southeast Asia Diabetes Drugs Sales Breakdown by Type
10.2.1 Southeast Asia Diabetes Drugs Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Diabetes Drugs Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Diabetes Drugs Sales Breakdown by Application
10.3.1 Southeast Asia K MT Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K MT Sales Breakdown by Application (2022-2027)
11 India Diabetes Drugs Market Facts & Figures
11.1 India Diabetes Drugs Sales by Company
11.1.1 India Diabetes Drugs Sales by Company (2016-2021)
11.1.2 India Diabetes Drugs Revenue by Company (2016-2021)
11.2 India Diabetes Drugs Sales Breakdown by Type
11.2.1 India Diabetes Drugs Sales Breakdown by Type (2016-2021)
11.2.2 India Diabetes Drugs Sales Breakdown by Type (2022-2027)
11.3 India Diabetes Drugs Sales Breakdown by Application
11.3.1 India Diabetes Drugs Sales Breakdown by Application (2016-2021)
11.3.2 India Diabetes Drugs Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Diabetes Drugs Business
12.1 Sanofi
12.1.1 Sanofi Corporation Information
12.1.2 Sanofi Business Overview
12.1.3 Sanofi Diabetes Drugs Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Sanofi Diabetes Drugs Products Offered
12.1.5 Sanofi Recent Development
12.2 Novo Nordisk
12.2.1 Novo Nordisk Corporation Information
12.2.2 Novo Nordisk Business Overview
12.2.3 Novo Nordisk Diabetes Drugs Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Novo Nordisk Diabetes Drugs Products Offered
12.2.5 Novo Nordisk Recent Development
12.3 MSD
12.3.1 MSD Corporation Information
12.3.2 MSD Business Overview
12.3.3 MSD Diabetes Drugs Sales, Revenue and Gross Margin (2016-2021)
12.3.4 MSD Diabetes Drugs Products Offered
12.3.5 MSD Recent Development
12.4 Astrazeneca
12.4.1 Astrazeneca Corporation Information
12.4.2 Astrazeneca Business Overview
12.4.3 Astrazeneca Diabetes Drugs Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Astrazeneca Diabetes Drugs Products Offered
12.4.5 Astrazeneca Recent Development
12.5 Takeda
12.5.1 Takeda Corporation Information
12.5.2 Takeda Business Overview
12.5.3 Takeda Diabetes Drugs Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Takeda Diabetes Drugs Products Offered
12.5.5 Takeda Recent Development
12.6 Novartis
12.6.1 Novartis Corporation Information
12.6.2 Novartis Business Overview
12.6.3 Novartis Diabetes Drugs Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Novartis Diabetes Drugs Products Offered
12.6.5 Novartis Recent Development
12.7 North China Pharmaceutical Group Corporation
12.7.1 North China Pharmaceutical Group Corporation Corporation Information
12.7.2 North China Pharmaceutical Group Corporation Business Overview
12.7.3 North China Pharmaceutical Group Corporation Diabetes Drugs Sales, Revenue and Gross Margin (2016-2021)
12.7.4 North China Pharmaceutical Group Corporation Diabetes Drugs Products Offered
12.7.5 North China Pharmaceutical Group Corporation Recent Development
12.8 Huadong Medicine
12.8.1 Huadong Medicine Corporation Information
12.8.2 Huadong Medicine Business Overview
12.8.3 Huadong Medicine Diabetes Drugs Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Huadong Medicine Diabetes Drugs Products Offered
12.8.5 Huadong Medicine Recent Development
12.9 Dongbao Pharmaceutical
12.9.1 Dongbao Pharmaceutical Corporation Information
12.9.2 Dongbao Pharmaceutical Business Overview
12.9.3 Dongbao Pharmaceutical Diabetes Drugs Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Dongbao Pharmaceutical Diabetes Drugs Products Offered
12.9.5 Dongbao Pharmaceutical Recent Development
12.10 Hisun Pharmacy
12.10.1 Hisun Pharmacy Corporation Information
12.10.2 Hisun Pharmacy Business Overview
12.10.3 Hisun Pharmacy Diabetes Drugs Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Hisun Pharmacy Diabetes Drugs Products Offered
12.10.5 Hisun Pharmacy Recent Development
12.11 KELUN
12.11.1 KELUN Corporation Information
12.11.2 KELUN Business Overview
12.11.3 KELUN Diabetes Drugs Sales, Revenue and Gross Margin (2016-2021)
12.11.4 KELUN Diabetes Drugs Products Offered
12.11.5 KELUN Recent Development
12.12 Ginwa
12.12.1 Ginwa Corporation Information
12.12.2 Ginwa Business Overview
12.12.3 Ginwa Diabetes Drugs Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Ginwa Diabetes Drugs Products Offered
12.12.5 Ginwa Recent Development
12.13 Tianan Pharmaceutical
12.13.1 Tianan Pharmaceutical Corporation Information
12.13.2 Tianan Pharmaceutical Business Overview
12.13.3 Tianan Pharmaceutical Diabetes Drugs Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Tianan Pharmaceutical Diabetes Drugs Products Offered
12.13.5 Tianan Pharmaceutical Recent Development
12.14 Jumpcan Pharmacy
12.14.1 Jumpcan Pharmacy Corporation Information
12.14.2 Jumpcan Pharmacy Business Overview
12.14.3 Jumpcan Pharmacy Diabetes Drugs Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Jumpcan Pharmacy Diabetes Drugs Products Offered
12.14.5 Jumpcan Pharmacy Recent Development
12.15 Guangzhou Baiyun Mountain
12.15.1 Guangzhou Baiyun Mountain Corporation Information
12.15.2 Guangzhou Baiyun Mountain Business Overview
12.15.3 Guangzhou Baiyun Mountain Diabetes Drugs Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Guangzhou Baiyun Mountain Diabetes Drugs Products Offered
12.15.5 Guangzhou Baiyun Mountain Recent Development
12.16 SHIJIAZHUANG YILING PHARMACEUTICAL
12.16.1 SHIJIAZHUANG YILING PHARMACEUTICAL Corporation Information
12.16.2 SHIJIAZHUANG YILING PHARMACEUTICAL Business Overview
12.16.3 SHIJIAZHUANG YILING PHARMACEUTICAL Diabetes Drugs Sales, Revenue and Gross Margin (2016-2021)
12.16.4 SHIJIAZHUANG YILING PHARMACEUTICAL Diabetes Drugs Products Offered
12.16.5 SHIJIAZHUANG YILING PHARMACEUTICAL Recent Development
12.17 Wanbang Biopharmaceuticals
12.17.1 Wanbang Biopharmaceuticals Corporation Information
12.17.2 Wanbang Biopharmaceuticals Business Overview
12.17.3 Wanbang Biopharmaceuticals Diabetes Drugs Sales, Revenue and Gross Margin (2016-2021)
12.17.4 Wanbang Biopharmaceuticals Diabetes Drugs Products Offered
12.17.5 Wanbang Biopharmaceuticals Recent Development
12.18 Gan & Lee
12.18.1 Gan & Lee Corporation Information
12.18.2 Gan & Lee Business Overview
12.18.3 Gan & Lee Diabetes Drugs Sales, Revenue and Gross Margin (2016-2021)
12.18.4 Gan & Lee Diabetes Drugs Products Offered
12.18.5 Gan & Lee Recent Development
12.19 Taloph
12.19.1 Taloph Corporation Information
12.19.2 Taloph Business Overview
12.19.3 Taloph Diabetes Drugs Sales, Revenue and Gross Margin (2016-2021)
12.19.4 Taloph Diabetes Drugs Products Offered
12.19.5 Taloph Recent Development
13 Diabetes Drugs Manufacturing Cost Analysis
13.1 Diabetes Drugs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Diabetes Drugs
13.4 Diabetes Drugs Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Diabetes Drugs Distributors List
14.3 Diabetes Drugs Customers
15 Market Dynamics
15.1 Diabetes Drugs Market Trends
15.2 Diabetes Drugs Drivers
15.3 Diabetes Drugs Market Challenges
15.4 Diabetes Drugs Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Diabetes Drugs Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Diabetes Drugs Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Diabetes Drugs Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Diabetes Drugs Sales (K MT) by Region (2016-2021)
Table 5. Global Diabetes Drugs Sales Market Share by Region (2016-2021)
Table 6. Global Diabetes Drugs Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Diabetes Drugs Revenue Share by Region (2016-2021)
Table 8. Global Diabetes Drugs Sales (K MT) Forecast by Region (2022-2027)
Table 9. Global Diabetes Drugs Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Diabetes Drugs Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Diabetes Drugs Revenue Share Forecast by Region (2022-2027)
Table 12. Global Diabetes Drugs Sales (K MT) of Key Companies (2016-2021)
Table 13. Global Diabetes Drugs Sales Share by Company (2016-2021)
Table 14. Global Diabetes Drugs Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Diabetes Drugs Revenue Share by Company (2016-2021)
Table 16. Global Diabetes Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diabetes Drugs as of 2020)
Table 17. Global Diabetes Drugs Average Price (USD/MT) of Key Company (2016-2021)
Table 18. Manufacturers Diabetes Drugs Manufacturing Sites and Area Served
Table 19. Manufacturers Diabetes Drugs Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Diabetes Drugs Sales (K MT) by Type (2016-2021)
Table 22. Global Diabetes Drugs Sales Share by Type (2016-2021)
Table 23. Global Diabetes Drugs Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Diabetes Drugs Price (USD/MT) by Type (2016-2021)
Table 25. Global Diabetes Drugs Sales Share by Type (2022-2027)
Table 26. Global Diabetes Drugs Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Diabetes Drugs Revenue Share by Type (2022-2027)
Table 28. Global Diabetes Drugs Price (USD/MT) by Type (2022-2027)
Table 29. Global Diabetes Drugs Sales (K MT) by Application (2016-2021)
Table 30. Global Diabetes Drugs Sales Share by Application (2016-2021)
Table 31. Global Diabetes Drugs Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Diabetes Drugs Price (USD/MT) by Application (2016-2021)
Table 33. Global Diabetes Drugs Sales (K MT) by Application (2022-2027)
Table 34. Global Diabetes Drugs Sales Share by Application (2022-2027)
Table 35. Global Diabetes Drugs Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Diabetes Drugs Revenue Share by Application (2022-2027)
Table 37. Global Diabetes Drugs Price (USD/MT) by Application (2022-2027)
Table 38. North America Diabetes Drugs Sales (K MT) by Company (2016-2021)
Table 39. North America Diabetes Drugs Sales Market Share by Company (2016-2021)
Table 40. North America Diabetes Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Diabetes Drugs Revenue Market Share by Company (2016-2021)
Table 42. North America Diabetes Drugs Sales by Type (2016-2021) & (K MT)
Table 43. North America Diabetes Drugs Sales Market Share by Type (2016-2021)
Table 44. North America Diabetes Drugs Sales by Type (2022-2027) & (K MT)
Table 45. North America Diabetes Drugs Sales Market Share by Type (2022-2027)
Table 46. North America Diabetes Drugs Sales by Application (2016-2021) & (K MT)
Table 47. North America Diabetes Drugs Sales Market Share by Application (2016-2021)
Table 48. North America Diabetes Drugs Sales by Application (2022-2027) & (K MT)
Table 49. North America Diabetes Drugs Sales Market Share by Application (2022-2027)
Table 50. Europe Diabetes Drugs Sales (K MT) by Company (2016-2021)
Table 51. Europe Diabetes Drugs Sales Market Share by Company (2016-2021)
Table 52. Europe Diabetes Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Diabetes Drugs Revenue Market Share by Company (2016-2021)
Table 54. Europe Diabetes Drugs Sales by Type (2016-2021) & (K MT)
Table 55. Europe Diabetes Drugs Sales Market Share by Type (2016-2021)
Table 56. Europe Diabetes Drugs Sales by Type (2022-2027) & (K MT)
Table 57. Europe Diabetes Drugs Sales Market Share by Type (2022-2027)
Table 58. Europe Diabetes Drugs Sales by Application (2016-2021) & (K MT)
Table 59. Europe Diabetes Drugs Sales Market Share by Application (2016-2021)
Table 60. Europe Diabetes Drugs Sales by Application (2022-2027) & (K MT)
Table 61. Europe Diabetes Drugs Sales Market Share by Application (2022-2027)
Table 62. China Diabetes Drugs Sales (K MT) by Company (2016-2021)
Table 63. China Diabetes Drugs Sales Market Share by Company (2016-2021)
Table 64. China Diabetes Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Diabetes Drugs Revenue Market Share by Company (2016-2021)
Table 66. China Diabetes Drugs Sales by Type (2016-2021) & (K MT)
Table 67. China Diabetes Drugs Sales Market Share by Type (2016-2021)
Table 68. China Diabetes Drugs Sales by Type (2022-2027) & (K MT)
Table 69. China Diabetes Drugs Sales Market Share by Type (2022-2027)
Table 70. China Diabetes Drugs Sales by Application (2016-2021) & (K MT)
Table 71. China Diabetes Drugs Sales Market Share by Application (2016-2021)
Table 72. China Diabetes Drugs Sales by Application (2022-2027) & (K MT)
Table 73. China Diabetes Drugs Sales Market Share by Application (2022-2027)
Table 74. Japan Diabetes Drugs Sales (K MT) by Company (2016-2021)
Table 75. Japan Diabetes Drugs Sales Market Share by Company (2016-2021)
Table 76. Japan Diabetes Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Diabetes Drugs Revenue Market Share by Company (2016-2021)
Table 78. Japan Diabetes Drugs Sales by Type (2016-2021) & (K MT)
Table 79. Japan Diabetes Drugs Sales Market Share by Type (2016-2021)
Table 80. Japan Diabetes Drugs Sales by Type (2022-2027) & (K MT)
Table 81. Japan Diabetes Drugs Sales Market Share by Type (2022-2027)
Table 82. Japan Diabetes Drugs Sales by Application (2016-2021) & (K MT)
Table 83. Japan Diabetes Drugs Sales Market Share by Application (2016-2021)
Table 84. Japan Diabetes Drugs Sales by Application (2022-2027) & (K MT)
Table 85. Japan Diabetes Drugs Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Diabetes Drugs Sales (K MT) by Company (2016-2021)
Table 87. Southeast Asia Diabetes Drugs Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Diabetes Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Diabetes Drugs Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Diabetes Drugs Sales by Type (2016-2021) & (K MT)
Table 91. Southeast Asia Diabetes Drugs Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Diabetes Drugs Sales by Type (2022-2027) & (K MT)
Table 93. Southeast Asia Diabetes Drugs Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Diabetes Drugs Sales by Application (2016-2021) & (K MT)
Table 95. Southeast Asia Diabetes Drugs Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Diabetes Drugs Sales by Application (2022-2027) & (K MT)
Table 97. Southeast Asia Diabetes Drugs Sales Market Share by Application (2022-2027)
Table 98. India Diabetes Drugs Sales (K MT) by Company (2016-2021)
Table 99. India Diabetes Drugs Sales Market Share by Company (2016-2021)
Table 100. India Diabetes Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Diabetes Drugs Revenue Market Share by Company (2016-2021)
Table 102. India Diabetes Drugs Sales by Type (2016-2021) & (K MT)
Table 103. India Diabetes Drugs Sales Market Share by Type (2016-2021)
Table 104. India Diabetes Drugs Sales by Type (2022-2027) & (K MT)
Table 105. India Diabetes Drugs Sales Market Share by Type (2022-2027)
Table 106. India Diabetes Drugs Sales by Application (2016-2021) & (K MT)
Table 107. India Diabetes Drugs Sales Market Share by Application (2016-2021)
Table 108. India Diabetes Drugs Sales by Application (2022-2027) & (K MT)
Table 109. India Diabetes Drugs Sales Market Share by Application (2022-2027)
Table 110. Sanofi Corporation Information
Table 111. Sanofi Description and Business Overview
Table 112. Sanofi Diabetes Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 113. Sanofi Diabetes Drugs Product
Table 114. Sanofi Recent Development
Table 115. Novo Nordisk Corporation Information
Table 116. Novo Nordisk Description and Business Overview
Table 117. Novo Nordisk Diabetes Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 118. Novo Nordisk Diabetes Drugs Product
Table 119. Novo Nordisk Recent Development
Table 120. MSD Corporation Information
Table 121. MSD Description and Business Overview
Table 122. MSD Diabetes Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 123. MSD Diabetes Drugs Product
Table 124. MSD Recent Development
Table 125. Astrazeneca Corporation Information
Table 126. Astrazeneca Description and Business Overview
Table 127. Astrazeneca Diabetes Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 128. Astrazeneca Diabetes Drugs Product
Table 129. Astrazeneca Recent Development
Table 130. Takeda Corporation Information
Table 131. Takeda Description and Business Overview
Table 132. Takeda Diabetes Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 133. Takeda Diabetes Drugs Product
Table 134. Takeda Recent Development
Table 135. Novartis Corporation Information
Table 136. Novartis Description and Business Overview
Table 137. Novartis Diabetes Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 138. Novartis Diabetes Drugs Product
Table 139. Novartis Recent Development
Table 140. North China Pharmaceutical Group Corporation Corporation Information
Table 141. North China Pharmaceutical Group Corporation Description and Business Overview
Table 142. North China Pharmaceutical Group Corporation Diabetes Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 143. North China Pharmaceutical Group Corporation Diabetes Drugs Product
Table 144. North China Pharmaceutical Group Corporation Recent Development
Table 145. Huadong Medicine Corporation Information
Table 146. Huadong Medicine Diabetes Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 147. Huadong Medicine Description and Business Overview
Table 148. Huadong Medicine Diabetes Drugs Product
Table 149. Huadong Medicine Recent Development
Table 150. Dongbao Pharmaceutical Corporation Information
Table 151. Dongbao Pharmaceutical Diabetes Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 152. Dongbao Pharmaceutical Description and Business Overview
Table 153. Dongbao Pharmaceutical Diabetes Drugs Product
Table 154. Dongbao Pharmaceutical Recent Development
Table 155. Hisun Pharmacy Corporation Information
Table 156. Hisun Pharmacy Description and Business Overview
Table 157. Hisun Pharmacy Diabetes Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 158. Hisun Pharmacy Diabetes Drugs Product
Table 159. Hisun Pharmacy Recent Development
Table 160. KELUN Corporation Information
Table 161. KELUN Description and Business Overview
Table 162. KELUN Diabetes Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 163. KELUN Diabetes Drugs Product
Table 164. KELUN Recent Development
Table 165. Ginwa Corporation Information
Table 166. Ginwa Description and Business Overview
Table 167. Ginwa Diabetes Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 168. Ginwa Diabetes Drugs Product
Table 169. Ginwa Recent Development
Table 170. Tianan Pharmaceutical Corporation Information
Table 171. Tianan Pharmaceutical Description and Business Overview
Table 172. Tianan Pharmaceutical Diabetes Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 173. Tianan Pharmaceutical Diabetes Drugs Product
Table 174. Tianan Pharmaceutical Recent Development
Table 175. Jumpcan Pharmacy Corporation Information
Table 176. Jumpcan Pharmacy Description and Business Overview
Table 177. Jumpcan Pharmacy Diabetes Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 178. Jumpcan Pharmacy Diabetes Drugs Product
Table 179. Jumpcan Pharmacy Recent Development
Table 180. Guangzhou Baiyun Mountain Corporation Information
Table 181. Guangzhou Baiyun Mountain Description and Business Overview
Table 182. Guangzhou Baiyun Mountain Diabetes Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 183. Guangzhou Baiyun Mountain Diabetes Drugs Product
Table 184. Guangzhou Baiyun Mountain Recent Development
Table 185. SHIJIAZHUANG YILING PHARMACEUTICAL Corporation Information
Table 186. SHIJIAZHUANG YILING PHARMACEUTICAL Description and Business Overview
Table 187. SHIJIAZHUANG YILING PHARMACEUTICAL Diabetes Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 188. SHIJIAZHUANG YILING PHARMACEUTICAL Diabetes Drugs Product
Table 189. SHIJIAZHUANG YILING PHARMACEUTICAL Recent Development
Table 190. Wanbang Biopharmaceuticals Corporation Information
Table 191. Wanbang Biopharmaceuticals Description and Business Overview
Table 192. Wanbang Biopharmaceuticals Diabetes Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 193. Wanbang Biopharmaceuticals Diabetes Drugs Product
Table 194. Wanbang Biopharmaceuticals Recent Development
Table 195. Gan & Lee Corporation Information
Table 196. Gan & Lee Description and Business Overview
Table 197. Gan & Lee Diabetes Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 198. Gan & Lee Diabetes Drugs Product
Table 199. Gan & Lee Recent Development
Table 200. Taloph Corporation Information
Table 201. Taloph Description and Business Overview
Table 202. Taloph Diabetes Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 203. Taloph Diabetes Drugs Product
Table 204. Taloph Recent Development
Table 205. Production Base and Market Concentration Rate of Raw Material
Table 206. Key Suppliers of Raw Materials
Table 207. Diabetes Drugs Distributors List
Table 208. Diabetes Drugs Customers List
Table 209. Diabetes Drugs Market Trends
Table 210. Diabetes Drugs Market Drivers
Table 211. Diabetes Drugs Market Challenges
Table 212. Diabetes Drugs Market Restraints
Table 213. Research Programs/Design for This Report
Table 214. Key Data Information from Secondary Sources
Table 215. Key Data Information from Primary Sources
List of Figures
Figure 1. Diabetes Drugs Product Picture
Figure 2. Global Diabetes Drugs Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Diabetes Drugs Sales Market Share by Application in 2021 & 2027
Figure 6. Diagnostic/Clinics Examples
Figure 7. ICUs Examples
Figure 8. Home Healthcare Examples
Figure 9. Global Diabetes Drugs Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Diabetes Drugs Sales Growth Rate (2016-2027) & (US$ Million)
Figure 11. Global Diabetes Drugs Sales (K MT) Growth Rate (2016-2027)
Figure 12. Global Diabetes Drugs Price Trends Growth Rate (2016-2027) (USD/MT)
Figure 13. Global Diabetes Drugs Revenue Market Share by Region: 2016 VS 2021
Figure 14. Global Diabetes Drugs Revenue Market Share by Region: 2021 VS 2027
Figure 15. North America Diabetes Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 16. North America Diabetes Drugs Sales (K MT) Growth Rate (2016-2027)
Figure 17. Europe Diabetes Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. Europe Diabetes Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 19. China Diabetes Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. China Diabetes Drugs Sales (Million USD) and Growth Rate (2016-2027)
Figure 21. Japan Diabetes Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. Japan Diabetes Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Diabetes Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Diabetes Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 25. India Diabetes Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. India Diabetes Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 27. Global 5 Largest Diabetes Drugs Players Market Share by Revenue in Diabetes Drugs: 2016 & 2020
Figure 28. Diabetes Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 29. Global Diabetes Drugs Revenue Share by Type (2016-2021)
Figure 30. Global Diabetes Drugs Revenue Growth Rate by Type in 2016 & 2020
Figure 31. Global Diabetes Drugs Revenue Share by Application (2016-2021)
Figure 32. Global Diabetes Drugs Revenue Growth Rate by Application in 2016 & 2020
Figure 33. North America Diabetes Drugs Sales Market Share by Type in 2020
Figure 34. North America Diabetes Drugs Sales Market Share by Application in 2020
Figure 35. Europe Diabetes Drugs Sales Market Share by Type in 2020
Figure 36. Europe Diabetes Drugs Sales Market Share by Application in 2020
Figure 37. China Diabetes Drugs Sales Market Share by Type in 2020
Figure 38. China Diabetes Drugs Sales Market Share by Application in 2020
Figure 39. Japan Diabetes Drugs Sales Market Share by Type in 2020
Figure 40. Japan Diabetes Drugs Sales Market Share by Application in 2020
Figure 41. Southeast Asia Diabetes Drugs Sales Market Share by Type in 2020
Figure 42. Southeast Asia Diabetes Drugs Sales Market Share by Application in 2020
Figure 43. India Diabetes Drugs Sales Market Share by Type in 2020
Figure 44. India Diabetes Drugs Sales Market Share by Application in 2020
Figure 45. Key Raw Materials Price Trend
Figure 46. Manufacturing Cost Structure of Diabetes Drugs
Figure 47. Manufacturing Process Analysis of Diabetes Drugs
Figure 48. Diabetes Drugs Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
世界のインスリン非依存型糖尿病治療薬市場規模・現状・予測（2021年-2027年） Diabetes is a metabolic disease, wherein the body is either unable to secret insulin (type 1 diabetes) or is unable to utilize the generated insulin (type 2 diabetes). Market Analysis and Insights: Global Non Insulin Anti diabetes Drugs Market The global Non Insulin Anti diabetes Drugs market size i…- 世界の糖尿病治療薬市場規模・現状・予測（2021年-2027年） Diabetes drugs are treatments for diabetes by lowering the sugar lower in the blood. Diabetes is a kind of disease with common symptoms such as frequent urination, increased thirst and weight loss. The most common drugs used are insulin and oral medications. Market Analysis and Insights: Global Diab…
- 1型糖尿病薬のグローバル市場調査 2019年 The global Type 1 Diabetes Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Type 1 Diabetes Drugs volume and value at global level, regional level and company level. From a global perspective, …
- 1型糖尿病薬のグローバル市場調査 2019年 The global Type 1 Diabetes Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Type 1 Diabetes Drugs volume and value at global level, regional level and company level. From a global perspective, …
- 世界の経口抗糖尿病薬市場規模・現状・予測（2021年-2027年） Diabetes is a chronic disease that occurs when the body cannot effectively use the produced insulin or the pancreas does not produce sufficient insulin. The pancreas is an organ that sits behind the stomach and releases hormones into the digestive system. Diabetes is categorized by increased levels …